Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.56 |
| ▸ | SNCA | P37840 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4375719 | 1.00 | SLC28A3 (0.56) | SLC28A3SNCAAPPTYRPOLB | |
| SCHEMBL5181117 | 0.96 | SLC28A3 (0.56) | SLC28A3SNCAAPP | |
| SCHEMBL19806793 | 0.89 | PTGS1 (0.63) | SLC28A3SNCAAPPTYRACHE | |
| SCHEMBL5191128 | 0.88 | SLC28A3 (0.55) | SLC28A3APPPOLB | |
| SCHEMBL29711107 | 0.88 | SLC28A3 (0.56) | SLC28A3SNCAAPPTYR | |
| SCHEMBL4368198 | 0.87 | SLC28A3 (0.54) | SLC28A3TYRPOLB | |
| SCHEMBL4368675 | 0.87 | SLC28A3 (0.54) | SLC28A3TYRPOLB | |
| SCHEMBL14120919 | 0.87 | POLB (0.59) | SNCAAPPTYRPOLB | |
| SCHEMBL19798066 | 0.85 | SNCA (0.67) | SNCAAPPTYRPOLBACHE | |
| SCHEMBL4371490 | 0.85 | SLC28A3 (0.55) | SLC28A3TYRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622563-B2 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20050272921-A1 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1544207-A1 | PROCESS FOR PRODUCING GLYCOSIDE | Mitsui Chemicals, Inc. (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272921-A1 | Process for producing glycoside | HAAO, OGA, MGAM | SLC28A3 3687/4885SNCA 3373/4885APP 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.